Myelomas

Studies related to cancers of the bone marrow plasma cell dyscrasias and malignacies.

• Clinical Impact of Bortezomib in Frontline Regimens for Patients with Multiple Myeloma
• New Drugs for Myeloma
• Advances in the Therapy of Chronic Idiopathic Myelofibrosis
• A Practical Update on the Use of Bortezomib in the Management of Multiple Myeloma EXPIRED
• VelcadeŽ: U.S. FDA Approval for the Treatment of Multiple Myeloma Progressing on Prior Therapy EXPIRED
• Update on theTreatment of Multiple Myeloma EXPIRED
• Nontraditional Cytotoxic Therapies for Relapsed/Refractory Multiple Myeloma EXPIRED
• Molecular Targets of Arsenic Trioxide in Malignant Cells EXPIRED